Joachim Grevel

2.9k total citations
64 papers, 2.2k citations indexed

About

Joachim Grevel is a scholar working on Transplantation, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Joachim Grevel has authored 64 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Transplantation, 21 papers in Pediatrics, Perinatology and Child Health and 13 papers in Molecular Biology. Recurrent topics in Joachim Grevel's work include Renal Transplantation Outcomes and Treatments (27 papers), Pharmacological Effects and Toxicity Studies (19 papers) and Antibiotics Pharmacokinetics and Efficacy (10 papers). Joachim Grevel is often cited by papers focused on Renal Transplantation Outcomes and Treatments (27 papers), Pharmacological Effects and Toxicity Studies (19 papers) and Antibiotics Pharmacokinetics and Efficacy (10 papers). Joachim Grevel collaborates with scholars based in United States, United Kingdom and Germany. Joachim Grevel's co-authors include Barry D. Kahan, Klaus Kutz, B D Kahan, Edgar A. Mueller, Johannes B. van Bree, B. Whiting, Barry D. Kahan, A. E. Johnston, David Holt and Andrew W. Kelman and has published in prestigious journals such as Science, Gut and Journal of Neurochemistry.

In The Last Decade

Joachim Grevel

63 papers receiving 2.1k citations

Peers

Joachim Grevel

TRANS

PPCH

SURGE

PHARM

Klaus Kutz Switzerland

Raymond G. Morris Australia

Leo Stolk Netherlands

Kimberly L. Napoli United States

Qais Mekki United States

Annick Rousseau France

Ikuko Yano Japan

R Hori Japan

Gabriele Kirchner Germany

Jean‐Guy Besner Canada

Klaus Kutz Switzerland

Joachim Grevel

420 ×0.4

TRANS

434 ×0.6

PPCH

320 ×0.7

SURGE

220 ×0.5

PHARM

297 ×0.9

Citations per year, relative to Joachim Grevel Joachim Grevel (= 1×) peers Klaus Kutz

Countries citing papers authored by Joachim Grevel

Since Specialization

Citations

This map shows the geographic impact of Joachim Grevel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joachim Grevel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joachim Grevel more than expected).

Fields of papers citing papers by Joachim Grevel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joachim Grevel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joachim Grevel. The network helps show where Joachim Grevel may publish in the future.

Co-authorship network of co-authors of Joachim Grevel

This figure shows the co-authorship network connecting the top 25 collaborators of Joachim Grevel. A scholar is included among the top collaborators of Joachim Grevel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joachim Grevel. Joachim Grevel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bursi, Roberta, et al.. (2017). Evaluation of the Population Pharmacokinetic Properties of Lidocaine and its Metabolites After Long-Term Multiple Applications of a Lidocaine Plaster in Post-Herpetic Neuralgia Patients. European Journal of Drug Metabolism and Pharmacokinetics. 42(5). 801–814. 8 indexed citations

Block, Michael S., Bart A. Ploeger, Joachim Grevel, et al.. (2016). Evaluation of exposure of regorafenib and its metabolites in cancer patients with renal impairment by modelling, simulation, and clinical study. Annals of Oncology. 27. vi538–vi538. 1 indexed citations

Ploeger, Bart A., Joachim Grevel, Michael S. Block, et al.. (2016). Evaluation of exposure of regorafenib (REG) and its metabolites in pediatric patients by modeling, simulation, and clinical study. Annals of Oncology. 27. vi539–vi539. 2 indexed citations

Cleton, Adriaan, et al.. (2015). P-261 Pharmacokinetics of regorafenib in the phase 3 CONCUR and CORRECT trials in patients with metastatic colorectal cancer (mCRC). Annals of Oncology. 26. iv76–iv76. 1 indexed citations

Mueller, Edgar A., John M. Kovarik, Johannes B. van Bree, et al.. (1994). Influence of a Fat-Rich Meal on the Pharmacokinetics of a New Oral Formulation of Cyclosporine in a Crossover Comparison with the Market Formulation. Pharmaceutical Research. 11(1). 151–155. 143 indexed citations

Mueller, Edgar A., et al.. (1994). Improved Dose Linearity of Cyclosporine Pharmacokinetics from a Microemulsion Formulation. Pharmaceutical Research. 11(2). 301–304. 230 indexed citations

Serino, Francesco, Joachim Grevel, Kimberly L. Napoli, B D Kahan, & Henry W. Strobel. (1993). Generation of oxygen free radicals during the metabolism of cyclosporine A: a cause-effect relationship with metabolism inhibition. Molecular and Cellular Biochemistry. 122(2). 101–112. 31 indexed citations

Kahan, Barry D., Maria Welsh, Richard J. Knight, et al.. (1992). Pharmacokinetic strategies for cyclosporin therapy in organ transplantation. Journal of Autoimmunity. 5. 333–341. 9 indexed citations

Katz, Stephen M., Ronald H. Kerman, Deborah L. Golden, et al.. (1991). Preemptive transplantation--an analysis of benefits and hazards in 85 cases.. PubMed. 51(2). 351–5. 54 indexed citations

10.

Grevel, Joachim & B D Kahan. (1991). Area Under the Curve Monitoring of Cyclosporine Therapy. Therapeutic Drug Monitoring. 13(2). 89–95. 24 indexed citations

11.

Grevel, Joachim, et al.. (1990). Steady-state concentrations of cyclosporine for therapeutic monitoring.. PubMed. 22(3). 1339–42. 4 indexed citations

12.

Canafax, D. M., Dullei Min, Arthur J. Matas, et al.. (1990). Effects of initial cyclosporine dose and timing on long‐term creatinine levels in cadaver renal transplantation. Clinical Transplantation. 4(5pt2). 321–328. 8 indexed citations

13.

Grevel, Joachim, Kimberly L. Napoli, Sara Gibbons, & B D Kahan. (1990). Area-Under-the-Curve Monitoring of Cyclosporine Therapy. Therapeutic Drug Monitoring. 12(1). 8–15. 12 indexed citations

14.

Naoumov, Nikolai V., J. Michael Tredger, John G. O’Grady, et al.. (1989). Cyclosporin A pharmacokinetics in liver transplant recipients in relation to biliary T-tube clamping and liver dysfunction.. Gut. 30(3). 391–396. 44 indexed citations

15.

Grevel, Joachim, Paul J. Thomas, & B. Whiting. (1989). Population Pharmacokinetic Analysis of Bisoprolol. Clinical Pharmacokinetics. 17(1). 53–63. 20 indexed citations

16.

Dominiak, Peter, Joachim Grevel, E. Abisch, et al.. (1988). The absolute systemic availability of a new oral formulation of co-dergocrine in healthy subjects. European Journal of Clinical Pharmacology. 35(1). 53–57. 3 indexed citations

17.

Kahan, Barry D. & Joachim Grevel. (1988). OPTIMIZATION OF CYCLOSPORINE THERAPY IN RENAL TRANSPLANTATION BY A PHARMACOKINETIC STRATEGY. Transplantation. 46(5). 631–644. 166 indexed citations

18.

Grevel, Joachim. (1987). Kinetic-Effect Models and Their Applications. Pharmaceutical Research. 4(2). 86–91. 8 indexed citations

19.

Grevel, Joachim, et al.. (1984). Radioreceptor Assay of Narcotic Analgesics in Serum. Pharmaceutical Research. 1(5). 209–214. 7 indexed citations

20.

Wagner, H. & Joachim Grevel. (1982). Neue herzwirksame Drogen II, Nachweis und Isolierung herzwirksamer Amine durch Ionenpaar-HPLC. Planta Medica. 44(1). 36–40. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact